Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1616 of 5804
-
Can early oxygen therapy prevent breathing failure after chest trauma?
Prevention CompletedIn blunt chest trauma patients without immediate life-threatening conditions, delayed respiratory failure and need for mechanical ventilation may still occur in 12 to 40% of patients, depending on the severity of the trauma, the preexisting conditions and the intensity of initial…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Laser eye surgery may offer a One-Time fix for reading glasses — a trial puts it to the test
Symptom relief CompletedThis study will be a 12-month, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation conducted at 8 to 14 sites. A total of 383 subjects will be enrolled to achieve approximately 268 treated subjects, resulting in at least 241 evaluable subj…
Phase: NA • Sponsor: AMO Development, LLC • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New drug aramchol aims to reverse fatty liver damage in phase 3 trial
Disease control TerminatedAn Open-Label Part was added: This part will enroll in selected sites which are less affected by the COVID-19 pandemic. 150 subjects with NASH and fibrosis confirmed by liver histology (F1-F3) will be randomized into 3 groups according to the post-baseline biopsy. The objectiv…
Phase: PHASE3 • Sponsor: Galmed Research and Development, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Mail-in HPV test could save lives of women skipping pap smears
Diagnosis Recruiting nowThe trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.
Phase: NA • Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New MS drug shows promise in Long-Term safety trial
Disease control CompletedPrimary Objective: To determine the long-term safety and tolerability of SAR442168 in RMS participants Secondary Objective: To evaluate efficacy of SAR442168 on disease activity, assessed by clinical and imaging methods
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug cocktail aims to boost lung cancer treatment
Disease control OngoingThis is a Phase I/Ib study whose purpose is to find out if combining an experimental drug called binimetinib with pembrolizumab is beneficial in people who have advanced non-small cell lung cancer. This study may also see if the combination is safe and may also find the best dose…
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Glue for nerves? polymer technique aims to speed up recovery after injury
Disease control CompletedCurrent strategies for peripheral nerve repair are severely limited. Even with current techniques, it can take months for regenerating axons to reach denervated target tissues when injuries are proximally located. This inability to rapidly restore the loss of function after axona…
Phase: PHASE1 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Laser surgery before radiation may ease urinary troubles in prostate cancer patients
Symptom relief Recruiting nowTo determine if holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) and/or urinary retention alters the treatment course for patients concurrently diagnosed with prostate cancer.
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Experimental drug combo shows promise for Tough-to-Treat gynecologic cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of triapine when given with radiation therapy and cisplatin in treating patients with stage IB2-IVA cervical or vaginal cancer. Triapine may stop the growth of cancer cells by blocking an enzyme needed for cell growth. Cis…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New antibody combo tested against hard-to-treat cancers
Disease control OngoingThe goal of this trial is to learn about the antibody GEN1042 when it is used alone and when it is used together with another antibody cancer drug, pembrolizumab (with or without chemotherapy), for treatment of participants with certain types of cancer.
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Needles or kneading? study tests acupuncture vs. massage for advanced cancer pain
Symptom relief OngoingThe purpose of this study is to compare the long-term effectiveness of acupuncture versus massage in people living with advanced cancer. The study will test how the two approaches compare in helping people with pain and its related symptoms and improving quality of life.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New schizophrenia drug shows promise in major trial
Disease control CompletedA clinical trial to study the efficacy and safety of an investigational drug in acutely psychotic people with schizophrenia. Participants in the study will either receive the drug being studied or a placebo. This study is accepting male and female participants between 13 years ol…
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a simple amino acid ease a devastating lung condition?
Disease control CompletedThe purpose of this study is to determine the safety and tolerance of an oral administration of methionine in the treatment of pulmonary alveolar proteinosis due to the double mutation Ala393Thr / Ser567Leu in the MARS gene. This disease is very severe and especially leads to chr…
Phase: PHASE1, PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can botox ease leg stiffness after stroke? new trial investigates
Symptom relief OngoingThe purpose of this study is to determine whether a single treatment with administration of 400 Units NT 201 (botulinum toxin) is superior to placebo (no medicine) for the treatment of lower limb spasticity caused by stroke or traumatic brain injury (Main Period). Participants wi…
Phase: PHASE3 • Sponsor: Merz Pharmaceuticals GmbH • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New hope for rare sarcoma? drug combo tested in 44 patients
Disease control CompletedThe yearly incidence of soft-tissue sarcomas (STS) in the USA is roughly 11,280 cases, and metastatic STS have a median overall survival of about 12 months. Sarcomas of the soft tissue are a heterogeneous group of malignant tumors of mesenchymal origin that originate in connectiv…
Phase: PHASE1, PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Personalized nutrition may stop weight gain after spinal injury
Prevention CompletedThis is a randomized clinical controlled trial (RCT) to investigate the impact of a personalized nutritional intervention on functional and clinical outcomes the first year after traumatic spinal cord injury. The long term goal is to prevent gain of body fat mass and obesity.
Phase: NA • Sponsor: Sunnaas Rehabilitation Hospital • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Blood biomarkers may spot ectopic pregnancies early
Diagnosis CompletedEctopic pregnancy (EP) is a pathology that affects 3%-16% of pregnancies in humans, being the main cause of morbidity and maternal mortality in the first trimester of pregnancy worldwide. The relevance of this problem has led to a demand on the scientific community, to obtain spe…
Sponsor: Vida Recoletas Sevilla • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Transplant Patients' vaccine shield under the microscope
Knowledge-focused Recruiting nowTransplantation is one of the most challenging and complex areas of modern medicine. Besides the intrinsic complexity of the surgical and medical procedures, transplantation medicine must take into account a flawless medical management before and after transplant, especially beca…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New drug combo shows promise for Tough-to-Treat lymphomas
Disease control CompletedThis phase I trial studies the side effects and best dose of olaparib when given together with high-dose chemotherapy in treating patients with lymphomas that have come back or does not treatment and are undergoing stem cell transplant. Drugs used in chemotherapy, such as olapari…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for Hard-to-Treat colorectal cancer: drug cocktail trial launches
Disease control OngoingCOLUMBIA-1 is a Phase 1b/2 platform study to evaluate the safety and efficacy of standard of care (FOLFOX plus bevacizumab) alone and in combination with novel oncology therapies in first-line metastatic microsatellite-stable colorectal cancer (MSS-CRC).
Phase: PHASE1, PHASE2 • Sponsor: MedImmune LLC • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC